Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Perry

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Cancer Treatment Reports|September 1, 1981
Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomasG J Vosika, K Briscoe, R W Carey, et al.
Cancer|February 1, 1995
Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group BD T Kiang, B J Kennedy, J Younger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patientsD Spiegelman, L H Maurer, J H Ware, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group BE E Vokes, A P Lyss, J E Herndon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1995
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B studyJ J Muscato, C Cirrincione, G Clamon, et al.
Medical and Pediatric Oncology|January 1, 1988
Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B TrialQ S Ringenberg, M C Perry, K J Propert, et al.
Seminars in Oncology|February 1, 1992
Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experienceM R Green, H Kreisman, D C Doll, et al.
The New England Journal of Medicine|November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupS M Keller, S Adak, H Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot studyJ Aisner, M Goutsou, L H Maurer, et al.
Psychotherapy and Psychosomatics|January 1, 1994
Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group BT A Ahles, P M Silberfarb, A C Rundle, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Cancer Treatment Reports|September 1, 1981
Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomasG J Vosika, K Briscoe, R W Carey, et al.
Cancer|February 1, 1995
Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group BD T Kiang, B J Kennedy, J Younger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patientsD Spiegelman, L H Maurer, J H Ware, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group BE E Vokes, A P Lyss, J E Herndon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1995
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B studyJ J Muscato, C Cirrincione, G Clamon, et al.
Medical and Pediatric Oncology|January 1, 1988
Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B TrialQ S Ringenberg, M C Perry, K J Propert, et al.
Seminars in Oncology|February 1, 1992
Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experienceM R Green, H Kreisman, D C Doll, et al.
The New England Journal of Medicine|November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupS M Keller, S Adak, H Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot studyJ Aisner, M Goutsou, L H Maurer, et al.
Psychotherapy and Psychosomatics|January 1, 1994
Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group BT A Ahles, P M Silberfarb, A C Rundle, et al.
Pageof 16